The role of bladder flap neourethra (BFN) in early urinary continence after laparoscopic RP

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042348

Enrollment

Unknown

Registered

2021-01-19

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Experimental group:Bladder flap neourethra(BRN) and urethral anastomosis after standard laparoscopic prostatectomy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Preoperative prostate biopsy confirmed the presence of prostate cancer, and lung CT, abdominal ultrasound, pelvic MRI and bone scan ruled out tumor metastasis. 2.Gleason score >= 7 (3+4); 3.Life expectancy is greater than 10 years; 4.The American society of anesthesiologists (ASA) classification for I-II level;

Exclusion criteria

Exclusion criteria: 1.Preoperative lung CT, abdominal ultrasound, pelvic MRI, and bone scan failed to rule out tumor metastasis 2.Uncorrected systemic disease or coagulation dysfunction, blood routine, etc., did not meet the perioperative indications; 3.Severe cardiopulmonary disease, unable to tolerate surgery; 4.With uncontrolled diabetes, high blood pressure and other underlying diseases, surgery is not acceptable.

Design outcomes

Primary

Measure	Time frame
Urinary control tare;	—

Secondary

Measure	Time frame
Maximum urethral pressure;Functional urethral length;Ureathral closure area;Estimated blood loss;Operation time;Positive surgical margin;Pathological stage;Pathological Gleason score;Neourethral length;	—

Countries

China

Contacts

Public ContactJiangping Wang

Urology of Taizhou People’s Hospital

mingzhujp@126.com+86 18700909001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026